Phreesia stock opened at $27.12 on Thursday. The company’s 50-day moving average price is $23.18 and its 200-day moving average price is $22.71. The company has a quick ratio of 1.77, a current ...

Phreesia (PHR) could be a solid addition to your portfolio given its recent upgrade to a Zacks Rank #2 (Buy). An upward trend in earnings estimates -- one of the most powerful forces impacting ...

Analyst Ryan MacDonald from Needham maintained a Buy rating on Phreesia (PHR – Research Report) and keeping the price target at $29.00. Discover outperforming stocks and invest smarter with Top ...

In a report released today, Jailendra Singh from Truist Financial assigned a Buy rating to Phreesia (PHR – Research Report). The company’s shares closed yesterday at $27.10. Discover ...

Phreesia (PHR) could be a solid addition to your portfolio given its recent upgrade to a Zacks Rank #2 (Buy). An upward trend in earnings estimates -- one of the most powerful forces impacting stock ...

Phreesia, Inc. (NYSE:PHR), a leading healthcare technology company specializing in patient intake management and workflow optimization, has been garnering attention from analysts and investors ...

5 analysts have shared their evaluations of Phreesia (NYSE:PHR) during the recent three months, expressing a mix of bullish and bearish perspectives. The following table summarizes their recent ...

Analyst Price Forecast Suggests 8.40% Upside As of December 24, 2024, the average one-year price target for Phreesia is $30.82/share. The forecasts range from a low of $24.24 to a high of $37.80.